CATSPERB
geneOn this page
Also known as FLJ14298
Summary
CATSPERB (catsper channel auxiliary subunit beta, HGNC:20500) is a protein-coding gene on chromosome 14q32.12, encoding Cation channel sperm-associated auxiliary subunit beta (Q9H7T0). Auxiliary component of the CatSper complex, a complex involved in sperm cell hyperactivation.
Predicted to be involved in cell differentiation and spermatogenesis. Predicted to be located in sperm principal piece. Predicted to be part of CatSper complex. Predicted to be active in cilium.
Source: NCBI Gene 79820 — RefSeq curated summary.
At a glance
- GWAS associations: 12
- Clinical variants (ClinVar): 149 total — 3 pathogenic
- MANE Select transcript:
NM_024764
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20500 |
| Approved symbol | CATSPERB |
| Name | catsper channel auxiliary subunit beta |
| Location | 14q32.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ14298 |
| Ensembl gene | ENSG00000133962 |
| Ensembl biotype | protein_coding |
| OMIM | 611169 |
| Entrez | 79820 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 5 protein_coding, 2 retained_intron, 1 nonsense_mediated_decay
ENST00000256343, ENST00000553329, ENST00000553676, ENST00000554560, ENST00000556429, ENST00000556661, ENST00000556901, ENST00000557036
RefSeq mRNA: 1 — MANE Select: NM_024764
NM_024764
CCDS: CCDS32142
Canonical transcript exons
ENST00000256343 — 27 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001129343 | 91580698 | 91581107 |
| ENSE00001399608 | 91691523 | 91691555 |
| ENSE00001401920 | 91672867 | 91673016 |
| ENSE00001402945 | 91674176 | 91674222 |
| ENSE00001405243 | 91659837 | 91659981 |
| ENSE00001407001 | 91669814 | 91669972 |
| ENSE00001409406 | 91693384 | 91693479 |
| ENSE00001411179 | 91704552 | 91704701 |
| ENSE00001412428 | 91683877 | 91683943 |
| ENSE00001415210 | 91693126 | 91693244 |
| ENSE00001417071 | 91725080 | 91725168 |
| ENSE00001420708 | 91729401 | 91729479 |
| ENSE00001426899 | 91719418 | 91719478 |
| ENSE00001429613 | 91708141 | 91708236 |
| ENSE00001433203 | 91723049 | 91723189 |
| ENSE00002445223 | 91731930 | 91732086 |
| ENSE00003466848 | 91587202 | 91587276 |
| ENSE00003506033 | 91589534 | 91589669 |
| ENSE00003520120 | 91639096 | 91639250 |
| ENSE00003541688 | 91636425 | 91636579 |
| ENSE00003554761 | 91587978 | 91588078 |
| ENSE00003556588 | 91624820 | 91625007 |
| ENSE00003576646 | 91610480 | 91610677 |
| ENSE00003581830 | 91617597 | 91617736 |
| ENSE00003597714 | 91621608 | 91621937 |
| ENSE00003646109 | 91591892 | 91592002 |
| ENSE00003685466 | 91608294 | 91608404 |
Expression profiles
Bgee: expression breadth ubiquitous, 123 present calls, max score 85.39.
Top tissues by expression
129 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| body of pancreas | UBERON:0001150 | 85.39 | gold quality |
| pancreas | UBERON:0001264 | 79.92 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.56 | silver quality |
| descending thoracic aorta | UBERON:0002345 | 76.50 | gold quality |
| thoracic aorta | UBERON:0001515 | 74.70 | gold quality |
| ascending aorta | UBERON:0001496 | 74.40 | gold quality |
| gall bladder | UBERON:0002110 | 73.58 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 72.31 | gold quality |
| endometrium | UBERON:0001295 | 71.97 | gold quality |
| minor salivary gland | UBERON:0001830 | 71.72 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 71.19 | gold quality |
| islet of Langerhans | UBERON:0000006 | 69.45 | gold quality |
| tonsil | UBERON:0002372 | 69.03 | gold quality |
| body of stomach | UBERON:0001161 | 67.22 | gold quality |
| stomach | UBERON:0000945 | 66.56 | gold quality |
| mucosa of stomach | UBERON:0001199 | 66.42 | gold quality |
| left coronary artery | UBERON:0001626 | 65.71 | gold quality |
| colonic epithelium | UBERON:0000397 | 64.80 | silver quality |
| right coronary artery | UBERON:0001625 | 64.49 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 64.22 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 64.22 | gold quality |
| rectum | UBERON:0001052 | 64.14 | gold quality |
| small intestine | UBERON:0002108 | 63.37 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 62.99 | gold quality |
| transverse colon | UBERON:0001157 | 62.99 | gold quality |
| testis | UBERON:0000473 | 62.44 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 62.44 | gold quality |
| prostate gland | UBERON:0002367 | 62.30 | gold quality |
| thyroid gland | UBERON:0002046 | 62.25 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 62.22 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-6142 | no | 2.14 |
| E-ANND-3 | no | 1.66 |
| E-GEOD-124858 | no | 1.60 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
17 targeting CATSPERB, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-3143 | 99.93 | 71.96 | 3104 |
| HSA-MIR-539-5P | 99.93 | 70.30 | 2855 |
| HSA-MIR-6508-5P | 99.92 | 70.67 | 2465 |
| HSA-MIR-8067 | 99.86 | 69.59 | 2260 |
| HSA-MIR-448 | 99.79 | 72.37 | 2103 |
| HSA-MIR-651-5P | 99.64 | 68.49 | 1104 |
| HSA-MIR-1290 | 99.59 | 69.90 | 2079 |
| HSA-MIR-7844-5P | 99.55 | 68.56 | 1428 |
| HSA-MIR-543 | 99.52 | 69.03 | 2595 |
| HSA-MIR-1276 | 99.36 | 68.18 | 1642 |
| HSA-MIR-4311 | 99.31 | 70.47 | 3041 |
| HSA-MIR-6739-3P | 99.22 | 68.84 | 1843 |
| HSA-MIR-583 | 98.71 | 67.44 | 1791 |
| HSA-MIR-6842-3P | 98.07 | 66.33 | 1325 |
| HSA-MIR-708-3P | 97.50 | 68.67 | 1082 |
| HSA-MIR-4327 | 97.21 | 67.71 | 676 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Catsperb | ENSMUSG00000047014 |
| rattus_norvegicus | Catsperb | ENSRNOG00000063175 |
Protein
Protein identifiers
Cation channel sperm-associated auxiliary subunit beta — Q9H7T0 (reviewed: Q9H7T0)
All UniProt accessions (6): A0A1B0GXC6, G3V2V0, G3V352, G3V584, Q9H7T0, H0YJA5
UniProt curated annotations — full annotation on UniProt →
Function. Auxiliary component of the CatSper complex, a complex involved in sperm cell hyperactivation. Sperm cell hyperactivation is needed for sperm motility which is essential late in the preparation of sperm for fertilization.
Subunit / interactions. Component of the CatSper complex or CatSpermasome composed of the core pore-forming members CATSPER1, CATSPER2, CATSPER3 and CATSPER4 as well as auxiliary members CATSPERB, CATSPERG, CATSPERD, CATSPERE, CATSPERZ, CATSPERT, CATSPERQ, CATSPERH and EFCAB9. HSPA1 may be an additional auxiliary complex member. The core complex members CATSPER1, CATSPER2, CATSPER3 and CATSPER4 form a heterotetrameric channel. The auxiliary CATSPERB, CATSPERG, CATSPERD and CATSPERE subunits form a pavilion-like structure over the pore which stabilizes the complex through interactions with CATSPER4, CATSPER3, CATSPER1 and CATSPER2 respectively. CATSPERH interacts with CATSPERB, further stabilizing the complex. CATSPERT interacts at least with CATSPERD and is required for targeting the CatSper complex in the flagellar membrane.
Subcellular location. Cell projection. Cilium. Flagellum membrane.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9H7T0-1 | 1 | yes |
| Q9H7T0-2 | 2 |
RefSeq proteins (1): NP_079040* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR028748 | CATSPERB | Family |
| IPR048786 | CATSPERB_N | Domain |
| IPR048788 | CATSPERB_2nd | Domain |
| IPR048789 | CATSPERB_C | Domain |
| IPR053903 | CATSPERB_head | Domain |
| IPR053904 | CATSPERB_Ig-like | Domain |
Pfam: PF15149, PF21541, PF21548, PF22830, PF22831
UniProt features (24 total): glycosylation site 11, disulfide bond 7, topological domain 2, chain 1, transmembrane region 1, splice variant 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H7T0-F1 | 84.99 | 0.51 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (7): 35–60, 189–302, 330–343, 718–816, 829–1037, 911–920, 922–937
Glycosylation sites (11): 690, 913, 921, 1010, 1015, 90, 100, 118, 226, 321, 618
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-1300642 | Sperm Motility And Taxes |
MSigDB gene sets: 83 (showing top):
GOBP_MALE_GAMETE_GENERATION, GOBP_SPERM_CAPACITATION, GOBP_ANATOMICAL_STRUCTURE_MATURATION, GOBP_CELL_MATURATION, GOBP_CILIUM_MOVEMENT, GOBP_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY, GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, chr14q32, WILCOX_RESPONSE_TO_PROGESTERONE_DN, GOCC_VOLTAGE_GATED_CALCIUM_CHANNEL_COMPLEX, GOCC_MOTILE_CILIUM, GOCC_CATION_CHANNEL_COMPLEX, GOCC_SPERM_PRINCIPAL_PIECE, GOCC_TRANSPORTER_COMPLEX
GO Biological Process (2): spermatogenesis (GO:0007283), cell differentiation (GO:0030154)
GO Molecular Function (0):
GO Cellular Component (7): plasma membrane (GO:0005886), cilium (GO:0005929), CatSper complex (GO:0036128), sperm principal piece (GO:0097228), membrane (GO:0016020), motile cilium (GO:0031514), cell projection (GO:0042995)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Fertilization | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| cellular developmental process | 1 |
| membrane | 1 |
| cell periphery | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
| voltage-gated calcium channel complex | 1 |
| sperm flagellum | 1 |
| cilium | 1 |
Protein interactions and networks
STRING
656 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CATSPERB | CATSPER1 | Q8NEC5 | 999 |
| CATSPERB | CATSPERD | Q86XM0 | 924 |
| CATSPERB | CATSPER4 | Q7RTX7 | 886 |
| CATSPERB | CATSPERG | Q6ZRH7 | 847 |
| CATSPERB | HSPA2 | P54652 | 838 |
| CATSPERB | CATSPER2 | Q96P56 | 796 |
| CATSPERB | CATSPER3 | Q86XQ3 | 795 |
| CATSPERB | EFCAB9 | A8MZ26 | 765 |
| CATSPERB | CATSPERE | Q5SY80 | 718 |
| CATSPERB | CATSPERZ | Q9NTU4 | 687 |
| CATSPERB | TC2N | Q8N9U0 | 626 |
| CATSPERB | HSPA1A | P08107 | 549 |
| CATSPERB | FAM178B | Q8IXR5 | 528 |
| CATSPERB | TXNDC8 | Q6A555 | 501 |
| CATSPERB | OR10H1 | Q9Y4A9 | 464 |
IntAct
0 interactions, top by confidence:
BioGRID (2): CATSPERB (Affinity Capture-MS), MYO6 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A0A0A6YXX9, A0A1Z2R986, A2RTF1, C6KI89, E9Q355, F5HFJ7, O36400, P03425, P04853, P09258, P09728, P0DP43, P12554, P12556, P16772, P19758, P21526, P22229, P28907, P35740, P35771, Q04547, Q2TAV2, Q2YDM0, Q3TBN1, Q499E0, Q4R6B2, Q5BKX0, Q5E9L2, Q5RDR5, Q66000, Q66001, Q68FB2, Q6AY76, Q6DFY8, Q6ZRH7, Q76B58, Q77MP7, Q77NN4, Q783Y1
Diamond homologs: A2RTF1, Q9H7T0
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| CATSPERB | “form complex” | “CatSpermasome complex” | binding |
Disease & clinical
Clinical variants and AI predictions
ClinVar
149 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 3 |
| Likely pathogenic | 0 |
| Uncertain significance | 124 |
| Likely benign | 14 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (3)
| Variant ID | HGVS | Classification |
|---|---|---|
| 1807775 | GRCh37/hg19 14q31.2-32.33(chr14:84537502-107285437)x3 | Pathogenic |
| 2674645 | NM_024764.4(CATSPERB):c.2126G>A (p.Arg709Gln) | Pathogenic |
| 813277 | GRCh37/hg19 14q31.2-32.2(chr14:84783523-96907490)x1 | Pathogenic |
SpliceAI
5379 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 14:91589528:CCCTA:C | donor_gain | 1.0000 |
| 14:91589532:A:AC | donor_gain | 1.0000 |
| 14:91589533:C:CC | donor_gain | 1.0000 |
| 14:91589533:CT:C | donor_gain | 1.0000 |
| 14:91589536:A:AC | donor_gain | 1.0000 |
| 14:91589536:AGTTT:A | donor_gain | 1.0000 |
| 14:91589537:G:C | donor_gain | 1.0000 |
| 14:91591890:A:AC | donor_gain | 1.0000 |
| 14:91591891:C:CC | donor_gain | 1.0000 |
| 14:91617592:CCTAC:C | donor_loss | 1.0000 |
| 14:91617595:ACC:A | donor_loss | 1.0000 |
| 14:91617596:C:G | donor_loss | 1.0000 |
| 14:91617639:A:C | donor_gain | 1.0000 |
| 14:91617733:AAAC:A | acceptor_gain | 1.0000 |
| 14:91617733:AAACC:A | acceptor_loss | 1.0000 |
| 14:91617734:AAC:A | acceptor_gain | 1.0000 |
| 14:91617734:AACC:A | acceptor_loss | 1.0000 |
| 14:91617737:C:CA | acceptor_loss | 1.0000 |
| 14:91617737:C:CC | acceptor_gain | 1.0000 |
| 14:91617738:T:A | acceptor_loss | 1.0000 |
| 14:91620758:AAGTC:A | donor_gain | 1.0000 |
| 14:91621935:CAA:C | acceptor_gain | 1.0000 |
| 14:91621938:C:CC | acceptor_gain | 1.0000 |
| 14:91624815:CCTA:C | donor_loss | 1.0000 |
| 14:91624816:CTA:C | donor_loss | 1.0000 |
| 14:91624817:TAC:T | donor_loss | 1.0000 |
| 14:91636424:C:A | donor_gain | 1.0000 |
| 14:91636437:A:AC | donor_gain | 1.0000 |
| 14:91636438:C:CC | donor_gain | 1.0000 |
| 14:91636442:T:TA | donor_gain | 1.0000 |
AlphaMissense
7392 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 14:91672977:A:G | W340R | 0.999 |
| 14:91672977:A:T | W340R | 0.999 |
| 14:91672975:C:A | W340C | 0.998 |
| 14:91672975:C:G | W340C | 0.998 |
| 14:91591980:C:G | C911S | 0.997 |
| 14:91591981:A:T | C911S | 0.997 |
| 14:91693162:A:C | S265R | 0.997 |
| 14:91693162:A:T | S265R | 0.997 |
| 14:91693164:T:G | S265R | 0.997 |
| 14:91591902:C:G | C937S | 0.996 |
| 14:91591903:A:T | C937S | 0.996 |
| 14:91591903:A:G | C937R | 0.995 |
| 14:91587257:A:G | F1026S | 0.994 |
| 14:91591981:A:G | C911R | 0.994 |
| 14:91669821:C:A | G427V | 0.994 |
| 14:91673007:A:G | C330R | 0.994 |
| 14:91691529:A:C | F286L | 0.994 |
| 14:91691529:A:T | F286L | 0.994 |
| 14:91691531:A:G | F286L | 0.994 |
| 14:91693187:A:G | L257P | 0.994 |
| 14:91719460:A:G | W110R | 0.994 |
| 14:91719460:A:T | W110R | 0.994 |
| 14:91589556:G:C | N978K | 0.993 |
| 14:91589556:G:T | N978K | 0.993 |
| 14:91591953:C:G | C920S | 0.993 |
| 14:91591954:A:T | C920S | 0.993 |
| 14:91608393:C:A | R870S | 0.993 |
| 14:91608393:C:G | R870S | 0.993 |
| 14:91659949:A:C | F440L | 0.993 |
| 14:91659949:A:T | F440L | 0.993 |
dbSNP variants (sampled 300 via entrez): RS1000013640 (14:91606821 G>A), RS1000014627 (14:91724488 C>G), RS1000049991 (14:91697557 T>C), RS1000061191 (14:91727574 T>C), RS1000082789 (14:91646270 C>T), RS1000097857 (14:91583402 G>C), RS1000103414 (14:91689896 C>T), RS1000145551 (14:91676194 A>G), RS1000171417 (14:91670055 A>C), RS1000187271 (14:91630161 T>G), RS1000199236 (14:91672783 C>G,T), RS1000213758 (14:91625845 G>A), RS1000227544 (14:91672871 T>A,C), RS1000256031 (14:91683498 T>C), RS1000301309 (14:91673198 G>A)
Disease associations
OMIM: gene MIM:611169 | disease phenotypes:
GenCC curated gene-disease
Mondo (1): male infertility (MONDO:0005372)
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
12 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003263_78 | Post bronchodilator FEV1 in COPD | 5.000000e-06 |
| GCST003518_92 | Daytime sleep phenotypes | 8.000000e-06 |
| GCST004599_172 | Mean platelet volume | 9.000000e-16 |
| GCST005956_47 | Waist-to-hip ratio adjusted for BMI | 7.000000e-07 |
| GCST005962_28 | Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test) | 7.000000e-07 |
| GCST008437_5 | Alzheimer’s disease in hypertension-negative individuals | 3.000000e-06 |
| GCST008762_12 | Intake of sweets | 2.000000e-06 |
| GCST009097_15 | Venous thromboembolism | 9.000000e-10 |
| GCST010703_103 | Brain morphology (MOSTest) | 8.000000e-21 |
| GCST90002395_209 | Mean platelet volume | 7.000000e-43 |
| GCST90002401_78 | Platelet distribution width | 2.000000e-28 |
| GCST90013658_7 | Myeloperoxidase-DNA complexes | 4.000000e-06 |
EFO canonical traits (9, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004314 | forced expiratory volume |
| EFO:0007828 | daytime rest measurement |
| EFO:0007788 | BMI-adjusted waist-hip ratio |
| EFO:0008007 | age at assessment |
| EFO:0008343 | sex interaction measurement |
| EFO:0010158 | sugar consumption measurement |
| EFO:0004346 | neuroimaging measurement |
| EFO:0007984 | platelet component distribution width |
| EFO:0011039 | myeloperoxidase (MPO)-DNA complex measurement |
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| D007248 | Infertility, Male | C12.100.500.430; C12.100.750.700; C12.200.294.430 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
14 total (human), top 14 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, increases methylation | 2 |
| sodium arsenite | affects methylation | 1 |
| aflatoxin B2 | increases methylation | 1 |
| bisphenol S | affects cotreatment, increases methylation | 1 |
| Fulvestrant | affects cotreatment, increases methylation | 1 |
| Acetaminophen | decreases expression | 1 |
| Estradiol | decreases expression | 1 |
| Progesterone | decreases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| Okadaic Acid | increases expression | 1 |
| S-Nitrosoglutathione | decreases expression | 1 |
| Particulate Matter | decreases expression | 1 |
Clinical trials (associated diseases)
125 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT02202382 | PHASE4 | COMPLETED | Effects of Korean Red Ginseng on Male Infertility |
| NCT02204826 | PHASE4 | COMPLETED | Effects of Korean Red Ginseng on Semen Parameters in Male Infertility Patients: a Randomized, Placebo-controlled, Double-blind Clinical Study |
| NCT03802864 | PHASE4 | COMPLETED | Post-operative Pain Control of Testicular Sperm Extraction Using Liposomal Bupivacaine |
| NCT06100432 | PHASE4 | ACTIVE_NOT_RECRUITING | Effect of Eurycoma Longifolia (DLBS5055) and Multivitamins (Vitamin C+Vitamin E+ β-carotene) for Infertile Males |
| NCT07523022 | PHASE4 | ENROLLING_BY_INVITATION | Comparison of the Effect of Gonadotropin and Clomiphene Citrate Treatment on Sperm Parameters and the Outcome of Assisted Reproductive Procedures in Subfertile Men Based on the APHRODITE Groups |
| NCT00975117 | PHASE3 | COMPLETED | Spermotrend in the Treatment of Male Infertility |
| NCT01407432 | PHASE3 | COMPLETED | Impact of Folates in the Care of the Male Infertility |
| NCT01895816 | PHASE3 | COMPLETED | Herbal Tonic Fertile Supplement(ZO2C5) |
| NCT02605070 | PHASE3 | TERMINATED | Pilot Study on the Effects of FSH Treatment on the Epigenetic Characteristics of Spermatozoa in Infertile Patients With Severe Oligozoospermia |
| NCT07402759 | PHASE3 | ACTIVE_NOT_RECRUITING | Impact of tdrd9 Gene Mutations in the Therapeutic Response to L-carnitine in Oligoasthenozoospermic Men |
| NCT01880086 | PHASE2 | COMPLETED | Clomiphene Citrate for the Treatment of Low Testosterone Associated With Chronic Opioid Pain Medication Administration |
| NCT02061384 | PHASE2 | COMPLETED | RA-2 13-cis Retinoic Acid (Isotretinoin) |
| NCT02421887 | PHASE2 | COMPLETED | Males, Antioxidants, and Infertility Trial |
| NCT05200663 | PHASE2 | UNKNOWN | Efficacy Comparison of Tamoxifen and Tamoxifen With Antioxidants on Semen Quality of Male With Idiopathic Infertility |
| NCT05290558 | PHASE2 | ACTIVE_NOT_RECRUITING | The Therapeutic Effects of Bu Shen Yi Jing Pill on Semen Quality in Sub Fertile Males: a Randomized Controlled Trial |
| NCT06091969 | PHASE2 | NOT_YET_RECRUITING | Supplementation for Male Subfertility |
| NCT01595308 | PHASE1 | COMPLETED | A Pilot Study to Evaluate the Effect of Pomegranate Juice on Semen Parameters in Healthy Male Volunteers |
| NCT02122211 | PHASE1 | COMPLETED | Choline Dehydrogenase and Sperm Function: Effects of Betaine |
| NCT02575924 | PHASE1 | UNKNOWN | Influence of Culture Media on Clinical Outcomes in Poor Responders or Severe Male Infertility |
| NCT01304927 | PHASE2/PHASE3 | COMPLETED | Vitamin D Supplementation and Male Infertility: The CBG-study a Randomized Clinical Trial |
| NCT02349945 | PHASE2/PHASE3 | COMPLETED | FSH Receptor Polymorphism p.N680S and Efficacy of FSH Therapy |
| NCT05222841 | PHASE2/PHASE3 | COMPLETED | The Effectiveness of Spermotrend Food Supplement in the Treatment of Male Infertility |
| NCT05616598 | PHASE2/PHASE3 | COMPLETED | Effect of New Oral Treatment for Hepatitis C Virus on Seminal Parameters |
| NCT02025270 | PHASE1/PHASE2 | COMPLETED | MSCs For Treatment of Azoospermic Patients |
| NCT04541459 | EARLY_PHASE1 | UNKNOWN | Validation of New Devices Against Ambient Electromagnetic Radiation |
| NCT05792813 | EARLY_PHASE1 | UNKNOWN | Efficacy and Safety of Linggui Yangyuan Paste in Patients With Male Infertility |
| NCT06188936 | EARLY_PHASE1 | COMPLETED | Home Semen Analysis Tests As a Screening Tool for Fertility Patients |
| NCT00012480 | Not specified | COMPLETED | Effect of Environmental Exposures on the Egg Fertilizing Ability of Human Sperm |
| NCT00044369 | Not specified | COMPLETED | Role of the Toxic Metal Cadmium in the Mechanism Producing Infertility With a Varicocele |
| NCT00119925 | Not specified | UNKNOWN | ‘SPRING’-Study: Subfertility Guidelines: Patient Related Implementation in the Netherlands Among Gynaecologists |
| NCT00178516 | Not specified | COMPLETED | Vitamin E and Male Infertility |
| NCT00315029 | Not specified | COMPLETED | Patient-Centered Implementation Trial for Single Embryo Transfer |
| NCT00341120 | Not specified | COMPLETED | Genetic Causes of Male Infertility |
| NCT00481403 | Not specified | COMPLETED | Study of Sperm Molecular Factors Implicated in Male Fertility |
| NCT00548977 | Not specified | COMPLETED | Genetic Studies Spermatogenic Failure |
| NCT00596739 | Not specified | COMPLETED | A Study of the Pre- and Post-operative Semen Analyses and Reproductive Hormone Levels of Men Undergoing Weight-reduction Surgery |
| NCT00756561 | Not specified | COMPLETED | HOP-2A - Intratesticular Hormone Levels |
| NCT00961558 | Not specified | TERMINATED | Canadian Varicocelectomy Initiative (CVI): Effects on Male Fertility and Testicular Function of Varicocelectomy |
| NCT01075334 | Not specified | UNKNOWN | Is a Carnitine Based Food Supplement (PorimoreTM) for Infertile Men Superior to Folate and Zinc With Regard to Pregnancy Rates in Intrauterine Insemination Cycles? |
| NCT01178463 | Not specified | UNKNOWN | Spermatogonial Stem Cells in Azoospermic Patients: a Comparison Between Obstructive and Non-obstructive Azoospermia |
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): male infertility, venous thromboembolism